04/01/2026
Today was the day! Congratulations to our very own Dr. Evan D. Schoenberg on being among the first in the U.S. to complete a corneal cross-linking procedure using FDA-approved Epioxa™ (riboflavin 5’-phosphate ophthalmic solution).
Epioxa™ is the first and only FDA-approved epithelium-on oxygen-enriched corneal cross-linking therapy.
Visit epioxa.com/important-safety-information for Important Safety Information.
#